Advanced Enzyme Technologies Limited (BOM:540025)
313.95
+0.70 (0.22%)
At close: Dec 4, 2025
BOM:540025 Revenue
Advanced Enzyme Technologies had revenue of 1.85B INR in the quarter ending September 30, 2025, with 26.31% growth. This brings the company's revenue in the last twelve months to 7.07B, up 14.11% year-over-year. In the fiscal year ending March 31, 2025, Advanced Enzyme Technologies had annual revenue of 6.37B with 2.09% growth.
Revenue (ttm)
7.07B
Revenue Growth
+14.11%
P/S Ratio
4.84
Revenue / Employee
20.91M
Employees
338
Market Cap
34.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.37B | 130.42M | 2.09% |
| Mar 31, 2024 | 6.24B | 832.31M | 15.39% |
| Mar 31, 2023 | 5.41B | 112.54M | 2.13% |
| Mar 31, 2022 | 5.29B | 275.42M | 5.49% |
| Mar 31, 2021 | 5.02B | 578.55M | 13.03% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.14T |
| State Bank of India | 3.57T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| Bharti Airtel | 1.95T |
| ICICI Bank | 1.91T |
Advanced Enzyme Technologies News
- 16 days ago - Advanced Enzyme Technologies Ltd (BOM:540025) Q2 2026 Earnings Call Highlights: Strong ... - GuruFocus
- 16 days ago - Q2 2026 Advanced Enzyme Technologies Ltd Earnings Call Transcript - GuruFocus
- 25 days ago - Advanced Enzyme shares jump 9% today after Q2 profit rises 32% YoY to Rs 43.3 crore - Business Upturn
- 1 year ago - Advanced Enzymes shares fall 8% after weak Q2 FY25 results - Business Upturn
- 1 year ago - Advanced Enzyme Technologies Q2 FY25: Revenue declines 7.4% YoY to ₹146.1 crore, Net Profit falls 5.1% YoY - Business Upturn